Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.9M Sell
107,100
-731
-0.7% -$84.4K 0.14% 86
2025
Q4
$11.4M Buy
107,831
+7,117
+7% +$668K 0.15% 85
2025
Q3
$8.45M Sell
100,714
-3,369
-3% -$277K 0.18% 98
2025
Q2
$8.24M Buy
104,083
+1,007
+1% +$80K 0.19% 102
2025
Q1
$9.25M Sell
103,076
-21,744
-17% -$2.03M 0.25% 84
2024
Q4
$12.3M Sell
124,820
-8,458
-6% -$872K 0.32% 60
2024
Q3
$15.1M Buy
133,278
+9,938
+8% +$1.18M 0.41% 47
2024
Q2
$15.3M Sell
123,340
-6,099
-5% -$786K 0.45% 40
2024
Q1
$17.1M Buy
+129,439
New +$16M 0.54% 34

Other funds holding MRK

Allianz's MRK Position: Q1 2026 in Review

Allianz reduced its Merck (MRK) stake by 0.68% in Q1 2026, selling an estimated $84.4K and leaving 107,100 shares worth $12.9M. The position accounts for 0.14% of the portfolio, ranked #86.

Allianz first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. The position peaked at $17.1M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Allianz held 107,100 shares of Merck worth $12.9M as of Q1 2026.
  • Allianz sold 731 Merck shares in Q1 2026, an estimated $84.4K.
  • Merck made up 0.14% of Allianz's portfolio in Q1 2026, its #86 holding.
  • Allianz first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • Allianz's Merck position peaked at $17.1M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Allianz's 13F filing for Q1 2026, filed 11 May 2026.